Veterinary antibiotics sector faces challenges like overuse of antibiotics, particularly in livestock farming. This rampant overprescription threatens the effectiveness of essential antibiotic classes, as routine administration creates selection pressure for resistant bacteria. These resistant pathogens can then be transmitted to humans, exacerbating a global public health crisis. Regulatory authorities are now imposing restrictions on the mass use of antibiotics for growth promotion in farm animals, which may negatively affect sales for veterinary antibiotic producers.
Market Opportunity - Emergence of novel classes of antibiotics
Veterinary antibiotics industry can witness growth with the emergence of novel antibiotic classes. As antibiotic resistance escalates, new drugs like oxazolidinones, pleuromutilins, and lipopeptides are being developed to combat resistant pathogens. Their unique mechanisms offer pharmaceutical companies a chance to capture market share with innovative treatments. For instance, ongoing research has led to the synthesis of novel pleuromutilin derivatives that show promising results against Gram-positive bacteria and fastidious Gram-negative pathogens.
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients